CG
LFCR icon

Cutler Group’s Lifecore Biomedical LFCR Stock Holding History

Cutler Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$1K – 6728
2017
Q1 		$1K Buy
+100
New +$1.27K ﹤0.01% 5888
2016
Q3 		– Sell
-25
Closed – – 7058
2016
Q2 		$0 Hold
25
– – ﹤0.01% 6984
2016
Q1 		$0 Buy
+25
New +$275 ﹤0.01% 6852

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Cutler Group's LFCR Position: Q2 2017 in Review

Cutler Group sold out of Lifecore Biomedical (LFCR) in Q2 2017, closing a stake of 100 shares — an estimated $1K sold.

Cutler Group first reported a position in LFCR in Q1 2016 and held it in 3 quarters. The position peaked at $1K in Q1 2017. 94 funds tracked by Wall St. Rank hold LFCR as of Q2 2017.

  • Cutler Group reported no remaining Lifecore Biomedical position as of Q2 2017 after selling out during the quarter.
  • Cutler Group sold 100 Lifecore Biomedical shares in Q2 2017, an estimated $1K.
  • Cutler Group first reported a position in Lifecore Biomedical in Q1 2016 and held it in 3 quarters.
  • Cutler Group's Lifecore Biomedical position peaked at $1K in Q1 2017.
  • 94 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.